Preventative Therapies for Respiratory Syncytial Virus (RSV) in Children: Where Are We Now?
- Marie-Hélène Bourassa; Larry Lands
Access Resources
About
This article reviews the current landscape of preventative therapies for respiratory syncytial virus (RSV) in children, focusing on the prefusion F protein as a key target for immunization. It reviews past and ongoing research efforts, including monoclonal antibodies, maternal immunization, and vaccines. The challenges of preventing RSV infections in pediatric patients are addressed, highlighting the importance of advancing immunization strategies to reduce the significant healthcare burden caused by RSV worldwide.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.